GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics
Open Access
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 8 (5), 986-994
- https://doi.org/10.1074/mcp.m800470-mcp200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Serum Protein N-Glycans Profiling for the Discovery of Potential Biomarkers for Nonalcoholic SteatohepatitisJournal of Proteome Research, 2009
- Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritisAnnals Of The Rheumatic Diseases, 2008
- Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and CirrhosisJournal of Virology, 2008
- Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patientsJournal of Viral Hepatitis, 2006
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology, 2003
- Structural Analysis of Human IgG-Fc Glycoforms Reveals a Correlation Between Glycosylation and Structural IntegrityJournal of Molecular Biology, 2003
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Alpha-2-macroglobulin and hepatic fibrosisDigestive Diseases and Sciences, 1994
- N-Acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: Increased activity in liver cirrhosis and hepatoma patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.JCI Insight, 1966